Hostname: page-component-7c8c6479df-p566r Total loading time: 0 Render date: 2024-03-29T04:53:08.332Z Has data issue: false hasContentIssue false

Emergence of Symptoms of Tourette's Syndrome during Fluvoxamine Treatment of Obsessive–Compulsive Disorder

Published online by Cambridge University Press:  02 January 2018

S. Fennig*
Affiliation:
Division of Epidemiology, Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, New York, USA
S. Naisberg Fennig
Affiliation:
Department of Child and Adolescent Psychiatry, State University of New York at Stony Brook, New York
M. Pato
Affiliation:
Department of Psychiatry, State University of New York at Stony Brook, New York
A. Weitzman
Affiliation:
Sackler Medical School, Tel Aviv University, and Geha Mental Health Center, Israel
*
Correspondence

Abstract

A 14-year-old boy with obsessive–compulsive disorder (OCD) developed, under fluvoxamine treatment, acute symptoms of Tourette's syndrome (TS) with aggravation of the OCD. The TS symptoms did not respond to dopamine blockers and disappeared only after withdrawal of fluvoxamine. Readministration of fluvoxamine caused a re-emergence of the same symptoms.

Type
Short papers
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Coleman, B. S. & Block, B. A. (1982) Fluvoxamine maleate, a serotoninergic antidepressant: a comparison with chlomipramine. Progress in Neuropsychopharmacology and Biological Psychiatry, 6, 475478.Google Scholar
Delgado, P. L., Goodman, W. K., Price, L. H., et al (1990) Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. British Journal of Psychiatry, 157, 763765.CrossRefGoogle ScholarPubMed
DeSimoni, M. G., Dal Toso, G., Fodritto, F., et al (1987) Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotoninergic afferences. Brain Research, 411, 8188.Google Scholar
Gately, P. F., Poon, S. L. & Segal, D. S. (1987) Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats. Psychopharmacology, 87, 400405.Google Scholar
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989) The Yale-Brown Obsessive-Compulsive Scale, I: development, use and reliability. Archives of General Psychiatry, 46, 10061011.Google Scholar
Goodman, W. K., McDougle, C. J., Price, L. H., et al (1990) Beyond the serotonin hypothesis: a role for dopamine in the forms of obsessive–compulsive disorder. Journal of Clinical Psychiatry, 51, 3643.Google Scholar
Goodman, W. K., Price, L. H., Woods, S. W., et al (1991) The pharmacological challenges in obsessive–compulsive disorder. In The Psychobiology of Obsessive–Compulsive Disorder (eds Zohar, H., Insel, T. & Rasmussen, S.), pp. 162186. New York: Springer.Google Scholar
Pauls, L. P., Towbin, K. E., Leckman, J. F., et al (1986) Gilles de la Tourette syndrome and obsessive–compulsive disorder: evidence supporting a genetic relationship. Archives of General Psychiatry, 43, 11801182.CrossRefGoogle ScholarPubMed
Riddle, M. A., Hardin, M. T., King, R., et al (1990) Fluoxetine treatment of children and adolescents with Tourette's and obsessive–compulsive disorders: preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 4548.Google Scholar
Shapiro, A. K., Shapiro, E. S., Young, J. G., et al (1988) Gilles de la Tourette Syndrome (2nd edn). New York: Raven Press.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.